Considine RV, Sinha MK, Heiman ML, et al
Seeds uncovers the cellular mechanisms behind GLP-1s and other peptides that can help people lose significant weight and treat type-2 diabetes
The prevention of steatohepatitis development is well-documented, as shown by the LEAN-J study, in which liraglutide attained histological resolution in 39% of patients, compared to 9% in the control group (Eguchi et al
Roehnelt explains how insulin functions in the body, what happens when insulin resistance develops, and why chronically elevated insulin drives inflammation, weight gain, metabolic dysfunction, and disease progression
Oral options typically carry lower manufacturing costs and eliminate the expenses associated with injection devices, cold chain shipping, and medical waste disposal
Even today, with still limited indications for GLP-1 use, one in eight Americans say theyve taken a GLP-1